Washington DC-based biotech startup dedicated to innovating cell-based technologies for treatments at the point-of-care. We believe in the possibility of patients becoming "self-repairing" by using their OWN stem cells to replenish and restore cells in degenerative diseases that have undergone damage. Cellular therapy is 10-15% of all clinical applications today and only rising with an aging population. Led by a team of scientists, our founders and members have previously succeeded in utilizing iterative iPSC technologies for rapid tissue-specific regeneration, and patient-specific primary cellular applications sanctioned by the FDA for investigational use in phase I clinical trials. Our team is innovating novel devices and applications using AI modeling to leverage personalized stem cell therapies for disease-specific needs. Currently approaching our next round, we are dedicated to enhancing stem cell treatment paradigms by changing the face of stem cell technologies at bed-side.
| Website | https://www.atpoint.io |
| Employees | 1 (1 on RocketReach) |
| Founded | 2022 |
| Address | 2001 L St NW, Washington, District of Columbia 20005, US |
| Industry | Biotechnology |
| Keywords | Point Of Care, Stem Cell Therapy, Stem Cell Treatment, Regenerative Medicine Technologies, Regenerative Medicine, Cellular Therapy, Cell Therapy, Cell-Based Therapies, Therapeutic Technologies, Advanced Therapies, Treatment Innovation, Biotechnology, New Therapies, Innovative Treatments, Healthcare Technology, Medical Technology, Medical Devices, Healthcare Innovation |
Looking for a particular AtPoint tx employee's phone or email?
Rawan al-Kharboosh is the CEO of AtPoint tx.
1 people are employed at AtPoint tx.
AtPoint tx is based in Washington, District of Columbia.